|Bid||2.86 x 0|
|Ask||2.93 x 0|
|Day's Range||2.81 - 2.94|
|52 Week Range||1.72 - 5.09|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.12|
LONDON, UK / ACCESSWIRE / November 29, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: BELLUS Health, Helius Medical ...
NEWTOWN, Pa., Nov. 17, 2017-- Helius Medical Technologies, Inc., a medical technology company focused on neurological wellness, has received numerous inquiries asking for clarification on the results of ...
NEW YORK, NY / ACCESSWIRE / November 14, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
NEWTOWN, Pa., Nov. 09, 2017-- Helius Medical Technologies, Inc., a medical technology company focused on neurological wellness, announced results from its registrational trial evaluating the safety and ...
NEWTOWN, Pa., Nov. 08, 2017-- Helius Medical Technologies, Inc.,, a medical technology company focused on neurological wellness, announced today that it will report the results of its registrational trial ...
VANCOUVER, Nov. 3, 2017 /CNW/ - Rockshield Capital Corp. (CSE:RKS), (US:CRUOF - News), (FSE:6BC.F - News) ("Rockshield" or the "Company") is pleased to provide an update on the Company's progress after a 300% increase in NAV year over year, including information with respect to the Company's future plans. Rockshield is an actively managed venture capital fund and merchant bank, focused on small cap high growth companies as we see this market segment with the greatest risk/reward potential.
NEWTOWN, Pa., Nov. 01, 2017-- Helius Medical Technologies, Inc. announced its upcoming presentation at the Canaccord Genuity Medical Technologies and Diagnostics Conference November 9th, 2017, at the Westin ...
LONDON, UK / ACCESSWIRE / October 25, 2017 / Pro-Trader Daily has lined up these stocks for our daily research reports coverage. Before the markets open, Pro-TD makes a brief technical snapshot of select ...